State OH
Clinical Trials in Ohio
Recruiting clinical trials with at least one study location in Ohio. Data updated daily from ClinicalTrials.gov.
Top Conditions in Ohio
NCT05558371 N/A
Recruiting
International CDKL5 Clinical Research Network
Condition
CDKL5
Enrollment
1,000 pts
Location
United States, Australia
Sponsor
University of Colorado, Denver
NCT07037433 Phase 3
Recruiting
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in P...
Condition
Atherosclerotic Cardiovascular Disease
Enrollment
12,800 pts
Location
United States, Argentina, Australia
Sponsor
Amgen
NCT04064060 Phase 3
Recruiting
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Ot...
Condition
Myelodysplastic Syndromes (MDS)
Enrollment
665 pts
Location
United States, Australia, Belgium
Sponsor
Celgene
NCT06817382 Phase 1
Recruiting
A Study to Investigate the Safety and Biodistribution of a Single Intrathecal (I...
Condition
Duchenne Muscular Dystrophy
Enrollment
12 pts
Location
United States
Sponsor
Insmed Gene Therapy LLC
NCT07084779 N/A
Recruiting
Investigation of Impact of AI on Prostate Cancer Workflow
Condition
Prostate Cancer
Enrollment
150 pts
Location
United States
Sponsor
Case Comprehensive Cancer Cent
NCT04947462 N/A
Recruiting
Proprioceptive Sensorimotor Integration With Neural Interfaces for Hand Prosthes...
Condition
Upper Limb Amputees
Enrollment
6 pts
Location
United States
Sponsor
VA Office of Research and Deve
NCT05556642 N/A
Recruiting
Relapsed and Refractory Hepatoblastoma: A Prospective Registry and Liver Tumor R...
Condition
Relapsed Hepatoblastoma
Enrollment
500 pts
Location
United States
Sponsor
Children's Hospital Medical Ce
NCT06385886 N/A
Recruiting
Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for S...
Condition
Sickle Cell Disease
Enrollment
500 pts
Location
United States
Sponsor
RTI International
NCT07219966 Phase 3
Recruiting
A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disor...
Condition
Alcohol Use Disorder
Enrollment
1,100 pts
Location
United States, Belgium, China
Sponsor
Eli Lilly and Company
NCT05977751 N/A
Recruiting
Prospective Multi-Center Trial for FemBloc Permanent Birth Control
Condition
Contraception
Enrollment
573 pts
Location
United States
Sponsor
Femasys Inc.
NCT04097145 N/A
Recruiting
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
Condition
Tricuspid Regurgitation
Enrollment
870 pts
Location
United States, Canada
Sponsor
Edwards Lifesciences
NCT03665675 EARLY_Phase 1
Recruiting
Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease ...
Condition
Allogeneic Hematopoietic Stem Cell Transplantation Recipient
Enrollment
20 pts
Location
United States
Sponsor
Sumithira Vasu
NCT07225686 Phase 3
Recruiting
Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sl...
Condition
Obesity
Enrollment
250 pts
Location
United States, Australia, Canada
Sponsor
Amgen
NCT06872905 N/A
Recruiting
Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endopros...
Condition
Aortoiliac Occlusive Disease
Enrollment
158 pts
Location
United States, Italy, Netherlands
Sponsor
W.L.Gore & Associates
NCT07221500 Phase 2
Recruiting
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyr...
Condition
Chronic Lymphocytic Leukemia (CLL)
Enrollment
100 pts
Location
United States, France, Italy
Sponsor
Nurix Therapeutics, Inc.
NCT05032105 Phase 1
Recruiting
The Impact of Focused Ultrasound Thalamotomy of the Anterior Nucleus for Focal-O...
Condition
Anxiety
Enrollment
10 pts
Location
United States
Sponsor
Ohio State University
NCT04951622 Phase 3
Recruiting
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
Condition
Myasthenia Gravis
Enrollment
199 pts
Location
United States, Australia, Belgium
Sponsor
Janssen Research & Development
NCT07037901 Phase 2
Recruiting
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants Wit...
Condition
Atopic Dermatitis
Enrollment
220 pts
Location
United States, Canada
Sponsor
Inmagene LLC
NCT06826612 Phase 1, Phase 2
Recruiting
A Randomized Study of SPK-10001 Gene Therapy in Participants With Huntington's D...
Condition
Huntington Disease
Enrollment
53 pts
Location
United States
Sponsor
Hoffmann-La Roche
NCT05622461 N/A
Recruiting
Setting Families on a Positive Path to Recovery After Pediatric TBI: Road-to-Rec...
Condition
Traumatic Brain Injury
Enrollment
200 pts
Location
United States
Sponsor
Children's Hospital Medical Ce
NCT04704661 Phase 1
Recruiting
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The ...
Condition
Advanced Breast Carcinoma
Enrollment
51 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT05797831 Phase 2, Phase 3
Recruiting
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endo...
Condition
Endometrial Cancer
Enrollment
268 pts
Location
United States, Austria, Canada
Sponsor
Kartos Therapeutics, Inc.
NCT07216872 N/A
Recruiting
Safety and Effectiveness of the BrainsWay Deep Transcranial Magnetic Stimulation...
Condition
Alcohol Use Disorder
Enrollment
186 pts
Location
United States, Israel
Sponsor
Brainsway
NCT06292780 Phase 1, Phase 2
Recruiting
A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or R...
Condition
Relapsed/Refractory Systemic Light Chain Amyloidosis
Enrollment
220 pts
Location
United States, South Korea, Spain
Sponsor
Regeneron Pharmaceuticals
NCT06925737 Phase 3
Recruiting
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Pros...
Condition
Prostate Cancer
Enrollment
1,440 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC